<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url><loc>https://health-fitness.news-articles.net/content/2017/05/04/biolife-solutions-to-report-first-quarter-2017-financial-results-and-provide-business-update-on-may-11-2017.html</loc><lastmod>2017-05-04T00:43:00+00:00</lastmod></url>
<url><loc>https://health-fitness.news-articles.net/content/2017/05/09/fda-grants-bavencio-avelumab-approval-for-a-common-type-of-advanced-bladder-cancer.html</loc><lastmod>2017-05-09T10:12:00+00:00</lastmod></url>
<url><loc>https://health-fitness.news-articles.net/content/2017/05/11/biolife-solutions-announces-q1-2017-financial-results.html</loc><lastmod>2017-05-11T10:26:00+00:00</lastmod></url>
<url><loc>https://health-fitness.news-articles.net/content/2017/05/12/lilly-announces-positive-results-for-three-phase-3-studies-of-galcanezumab-for-the-prevention-of-episodic-and-chronic-migraine.html</loc><lastmod>2017-05-12T00:58:00+00:00</lastmod></url>
<url><loc>https://health-fitness.news-articles.net/content/2017/05/17/lilly-to-present-results-from-pivotal-breast-cancer-study-of-abemaciclib-and-new-portfolio-data-at-asco-2017.html</loc><lastmod>2017-05-17T11:58:00+00:00</lastmod></url>
<url><loc>https://health-fitness.news-articles.net/content/2017/05/31/lilly-announces-phase-3-range-urothelial-cancer-trial-of-cyramza-ramucirumab-met-primary-endpoint-improving-progression-free.html</loc><lastmod>2017-05-31T01:12:00+00:00</lastmod></url>
</urlset>